78 related articles for article (PubMed ID: 27180197)
21. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
23. A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.
Pouryasin M; Sharafi H; Behnava B; Alavian SM; Keshvari M; Pouryasin A
Lab Med; 2017 Feb; 48(1):51-56. PubMed ID: 28057801
[TBL] [Abstract][Full Text] [Related]
24. Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
Nagaoki Y; Imamura M; Kawakami Y; Kan H; Fujino H; Fukuhara T; Kobayashi T; Ono A; Nakahara T; Naeshiro N; Urabe A; Yokoyama S; Miyaki D; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Aikata H; Takahashi S; Hayes CN; Ochi H; Chayama K;
Hepatol Res; 2014 Dec; 44(14):E447-54. PubMed ID: 24690180
[TBL] [Abstract][Full Text] [Related]
25. IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.
Mori N; Imamura M; Kawakami Y; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Hayes CN; Aikata H; Miki D; Ochi H; Honda Y; Takaki S; Tsuji K; Chayama K;
Hepatol Res; 2017 Mar; 47(3):E5-E13. PubMed ID: 27027531
[TBL] [Abstract][Full Text] [Related]
26. Impact of IFNL4-∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals.
Backus LI; Shahoumian TA; Belperio PS; Winters M; Prokunina-Olsson L; O'Brien TR; Holodniy M
Diagn Microbiol Infect Dis; 2018 Sep; 92(1):34-36. PubMed ID: 29866411
[TBL] [Abstract][Full Text] [Related]
27. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
Petta S; Valenti L; Tuttolomondo A; Dongiovanni P; Pipitone RM; Cammà C; Cabibi D; Di Marco V; Fracanzani AL; Badiali S; Nobili V; Fargion S; Grimaudo S; Craxì A
Hepatology; 2017 Dec; 66(6):1885-1893. PubMed ID: 28741298
[TBL] [Abstract][Full Text] [Related]
28. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
[TBL] [Abstract][Full Text] [Related]
29. Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.
Noureddin M; Rotman Y; Zhang F; Park H; Rehermann B; Thomas E; Liang TJ
Genes Immun; 2015; 16(5):321-9. PubMed ID: 26020282
[TBL] [Abstract][Full Text] [Related]
30. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
Aiken T; Garber A; Thomas D; Hamon N; Lopez R; Konjeti R; McCullough A; Zein N; Fung J; Askar M; John BV
PLoS One; 2016; 11(11):e0166998. PubMed ID: 27875564
[TBL] [Abstract][Full Text] [Related]
31. IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
Miyamura T; Kanda T; Nakamoto S; Arai M; Nakamura M; Wu S; Jiang X; Sasaki R; Haga Y; Yasui S; Ooka Y; Chiba T; Imazeki F; Mikami S; Yokosuka O
Int J Hepatol; 2014; 2014():723868. PubMed ID: 25548683
[TBL] [Abstract][Full Text] [Related]
32. A Knockout IFNL4 Variant Is Associated With Protection From Sexually Transmitted HIV-1 Infection.
Jaimes-Bernal C; Rallón N; Benito JM; Omar M; Gómez-Vidal MA; Márquez FJ; Sánchez-Arcas B; Trujillo M; Royo JL; Saulle I; Biasin M; Rivero-Juárez A; Caruz A
J Infect Dis; 2019 Feb; 219(5):772-776. PubMed ID: 30289470
[TBL] [Abstract][Full Text] [Related]
33. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
[TBL] [Abstract][Full Text] [Related]
34. Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.
Rosenberg BR; Freije CA; Imanaka N; Chen ST; Eitson JL; Caron R; Uhl SA; Zeremski M; Talal A; Jacobson IM; Rice CM; Schoggins JW
J Infect Dis; 2018 Jan; 217(4):650-655. PubMed ID: 29165633
[TBL] [Abstract][Full Text] [Related]
35. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
36. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
Lang Kuhs KA; Kuniholm MH; Pfeiffer RM; Chen S; Desai S; Edlin BR; Peters MG; Plankey M; Sharp GB; Strickler HD; Villacres MC; Quinn TC; Gange SJ; Prokunina-Olsson L; Greenblatt RM; O'Brien TR
PLoS One; 2015; 10(10):e0138827. PubMed ID: 26431156
[TBL] [Abstract][Full Text] [Related]
37.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
38. Impact of
Pedergnana V; Irving WL; Barnes E; McLauchlan J; Spencer CCA
J Interferon Cytokine Res; 2019 Oct; 39(10):642-649. PubMed ID: 31260374
[TBL] [Abstract][Full Text] [Related]
39. IFNL4: Notable variants and associated phenotypes
Fang MZ; Jackson SS; O'Brien TR
Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
[TBL] [Abstract][Full Text] [Related]
40. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
O'Brien TR; Jackson SS
J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
